Image via Wikipedia
Boston Scientific Corp. discovered a documentation error in its regulatory filings “in the last few days” that led the company to halt sales of its cardiac defibrillators.The two devices that the Natick, Mass.-based company have temporarily shelved are its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
Source.